Reason for request
Inclusion on the list of medicines approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this medicinal product is substantial. |
Clinical Added Value
| moderate |
BERINERT provides a moderate improvement in actual benefit (IAB III) in terms of effectiveness in managing episodes of hereditary angioedema in adults and children. |
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
p6A048KzGgCqQGdJ
